|
|
Mechanisms of leukemogenesis in Down syndrome |
| 5 R01 CA101774-20 |
CRISPINO, JOHN D |
NCI |
2021 |
|
|
Sarcoglycan in Myopathy and Muscle Membrane Stability |
| 5 R01 HL061322-22 |
|
NHLBI |
2021 |
|
|
Combinatorial Approaches to Improved Blood-contacting Polymer Biomaterials |
| 5 R01 HL153231-02 |
|
NHLBI |
2021 |
|
|
MiR-193a-5p as a Regulator of Intersectin1-short and Clathrin-Mediated Endocytosis in Alzheimer's Disease. |
| 1 R36 AG073792-01 |
|
NIA |
2021 |
|
|
Investigating the vulnerability of WFS1-expressing excitatory neurons to tau pathology in early Alzheimers disease. |
| 5 K01 AG056673-05 |
|
NIA |
2021 |
|
|
Training for the Multiscale and Multimodal Analysis of Biomarkers in Alzheimer's Disease |
| 5 T32 AG058507-04 |
|
NIA |
2021 |
|
|
Project 2 Title: The brain brush border and microglial activation in response to ethanol |
| 2 P50 AA024333-06 |
DAVALOS, DIMITRIOS |
NIAAA |
2021 |
|
|
Fetal alcohol exposure: effects on immunity of the premature newborn |
| 5 R01 AA027020-03 |
GAUTHIER, THERESA WANZOR |
NIAAA |
2021 |
|
|
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome |
| 5 R01 AI141662-03 |
YEAGER, MICHAEL E |
NIAID |
2021 |
|
|
Immune regulation and gastrointestinal co-morbidity in autism spectrum disorders |
| 5 R01 HD090214-04 |
ASHWOOD, PAUL |
NICHD |
2021 |
